Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial
2011
Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis
1996
Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ- and JNK1-Dependent Inflammation
2010
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
Animal Models of Cigarette Smoke-Induced COPD*
2002
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Adenosine mediates IL-13–induced inflammation and remodeling in the lung and interacts in an IL-13–adenosine amplification pathway
2003
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Interleukin-18 in induced sputum: Association with lung function in chronic obstructive pulmonary disease
2009
Interleukin-17 Family Members and Inflammation
2004 Standout
Systemic inflammation in chronic obstructive pulmonary disease
2003
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
2004
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
1999
Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine
2003
Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
2008
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
COPD exacerbations {middle dot} 5: Management
2006
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial
2000
COPD exacerbations: defining their cause and prevention
2007
Asthma: defining of the persistent adult phenotypes
2006
Asthma
2017 Standout
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
2003
The cellular composition of induced sputum in chronic obstructive pulmonary disease
1999
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
1996
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
2007
The development of allergic inflammation
2008 StandoutNature
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase– and cathepsin-dependent emphysema
2000
Mediators of Chronic Obstructive Pulmonary Disease
2004
Immunity, Inflammation, and Cancer
2010 Standout
Pulmonary Inflammation and Emphysema
2007
Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.
1996
Transient receptor potential (TRP) channels as potential drug targets in respiratory disease
2003
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
2003
Matrix metalloproteinases as modulators of inflammation and innate immunity
2004 Standout
Basophils in airway disease
2002
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
2005 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The Role of Infection in COPD
1998
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Increased MCP-1 and MIP-1β in bronchoalveolar lavage fluid of chronic bronchitics
1999
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease
1998
Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis
1995
Exacerbations of chronic obstructive pulmonary disease
2007
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD
2012
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
2005
Interleukin-18 production and pulmonary function in COPD
2007
Airway Mucus Function and Dysfunction
2010 Standout
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13–induced inflammation and remodeling
2002
Acute effects of cigarette smoke on inflammation and oxidative stress: a review
2004
Upregulation of Gelatinases A and B, Collagenases 1 and 2, and Increased Parenchymal Cell Death in COPD
2000
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.
1997
Idiopathic pulmonary fibrosis
2011 Standout
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.
1997
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Neutrophils and the Pathogenesis of COPD
2002
Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis
1994
Alternative activation of macrophages
2003 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
2003
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
2000
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Transforming Growth Factor β 1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease
1998
Severity of Airflow Limitation Is Associated with Severity of Airway Inflammation in Smokers
1998
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
2019
Occupational Asthma
2005
Increased VIP-Positive Nerve Fibers in the Mucous Glands of Subjects with Chronic Bronchitis
1997
Endothelial Sulfated Sialyl Lewis x Glycans, Putative L-Selectin Ligands, Are Preferentially Expressed in Bronchial Asthma but Not in Other Chronic Inflammatory Lung Diseases
2000
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers
2000
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic Bronchitis
1998
The Development of Emphysema in Cigarette Smoke-exposed Mice Is Strain Dependent
2004
Increased Expression of Heme Oxygenase (HO)-1 in Alveolar Spaces and HO-2 in Alveolar Walls of Smokers
2001
Amplification of Inflammation in Emphysema and Its Association with Latent Adenoviral Infection
2001 Standout
Neutrophilic Inflammation in Severe Persistent Asthma
1999
Inflammatory Reaction in Pulmonary Muscular Arteries of Patients with Mild Chronic Obstructive Pulmonary Disease
1999
CD8 + T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Biopsy Neutrophilia, Neutrophil Chemokine and Receptor Gene Expression in Severe Exacerbations of Chronic Obstructive Pulmonary Disease
2003
Increased Levels of Elastase and α 1 -Antitrypsin in Sputum of Asthmatic Patients
1998
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Human Eosinophils Induce Mucin Production in Airway Epithelial Cells Via Epidermal Growth Factor Receptor Activation
2001
IL-17 and Th17 Cells
2009 Standout
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Carbohydrate Sulfotransferases of the GalNAc/Gal/GlcNAc6ST Family
2002 StandoutNobel
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
The Asthma Epidemic
2006 Standout
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
1995
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13–induced inflammation and remodeling
2002
Physical Activity and Public Health in Older Adults
2007 Standout
Adenosine mediates IL-13–induced inflammation and remodeling in the lung and interacts in an IL-13–adenosine amplification pathway
2003
Airway eosinophilia and expression of interleukin‐5 protein in asthma and in exacerbations of chronic bronchitis
1996
IL-13-Induced Chemokine Responses in the Lung: Role of CCR2 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
2002
Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis
1997
Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men
1999
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of A Roggeri being referenced
Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis.
1994
Effect of smoking cessation on airway inflammation in chronic bronchitis.
1995
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa.
1996
Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage.
1995
The role of histology in idiopathic pulmonary fibrosis: An update
2010
Airway eosinophilia in chronic bronchitis during exacerbations.
1994